NCBiotech News

Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases including Pompe disease and epilepsy.

When North Carolina State University leaders asked, “What can we be best at,” agriculture research and innovation was a compelling answer. And it will start taking physical form later this year as the Plant Sciences Initiative (PSI).

Why is the U.S. Department of Defense Advanced Research Projects Agency (DARPA) interested in agriculture? 

North Carolina entrepreneurs looking to validate and advance their business startup ideas are being encouraged to apply now through May 14 for NC IDEA’s new “no strings attached” SEED Micro-Grant Pilot Program.

Morrisville-based Metabolon, a metabolomics company, will analyze biomarkers of wellness and disease in U.S. veterans through the Million Veteran Program (MVP) of the U.S. Department of Veterans Affairs.

Worldwide Clinical Trials of Morrisville has formed a strategic alliance with KinderPharm of Exton, Pa., to create what the two clinical research organizations (CROs) are calling the world’s first center of excellence for pediatric drug development and clinical research for the pharmaceutical industry.

Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug clinical trials, is expanding again in High Point to meet growing business demand for its services.

Grifols, a Spanish biotherapeutics company that employs some 2,500 people in North Carolina, donated more than 25 million international units (IU) of blood clotting factor in 2017, as part of an eight-year commitment to changing the lives of people with hemophilia in 47 countries who have limited access to treatment.

​​​​​​​Good timing had a lot to do with the success of FoodLogiQ, the Durham-based software as a service (SaaS) provider of food traceability, safety and supply chain transparency, says co-founder Andrew Kennedy.

Camras Vision, an NCBiotech portfolio company developing a new medical device for treating glaucoma, has closed on $5.7M in equity funding in a Series A round.

Two North Carolina medical technology companies are among the six chosen to pitch their wares next Monday, April 9, during the inaugural Southeast Region Pitch Event at the North Carolina Biotechnology Center.

Biovet S.A. Laboratories, a Spanish animal-nutrition company, has established a small office in Research Triangle Park to better serve the North American market.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to Fennec Pharma’s drug designed to protect the hearing of children undergoing chemotherapy.

Grifols, already the largest private employer in Johnston County, is about to get even bigger.

On April 20, the Rotary Club of Research Triangle Park will host its first STEAM: Changing the World Event.